|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 1,377.50 GBX | -0.11% |
|
+4.24% | -11.13% |
| Mar. 23 | Hikma Pharmaceuticals PLC(LSE:HIK) added to FTSE 250 (Ex Investment Companies) Index | CI |
| Mar. 22 | Hikma Pharmaceuticals PLC(LSE:HIK) added to FTSE 250 Index | CI |
| Capitalization | 4.03B 3.42B 3.13B 2.98B 5.5B 375B 5.62B 36.75B 14.45B 181B 15.11B 14.79B 639B | P/E ratio 2026 * |
9.73x | P/E ratio 2027 * | 8.77x |
|---|---|---|---|---|---|
| Enterprise value | 5.4B 4.58B 4.2B 3.99B 7.38B 502B 7.53B 49.3B 19.39B 242B 20.27B 19.85B 857B | EV / Sales 2026 * |
1.56x | EV / Sales 2027 * | 1.44x |
| Free-Float |
65.88% | Yield 2026 * |
4.56% | Yield 2027 * | 4.83% |
Last Transcript: Hikma Pharmaceuticals PLC
| 1 day | -0.11% | ||
| 1 week | +4.20% | ||
| Current month | +9.24% | ||
| 1 month | +10.64% | ||
| 3 months | -10.73% | ||
| 6 months | -22.39% | ||
| Current year | -11.13% |
| 1 week | 1,320.5 |  | 1,387.5 |
| 1 month | 1,222 | | 1,387.5 |
| Current year | 1,187 | | 1,691 |
| 1 year | 1,187 | | 2,164 |
| 3 years | 1,187 | | 2,360 |
| 5 years | 1,174.5 | | 2,703 |
| 10 years | 814.2 | | 2,768 |
| Manager | Title | Age | Since |
|---|---|---|---|
Said Darwazah
CEO | Chief Executive Officer | 68 | 2025-11-30 |
Hill Julie
CMP | Compliance Officer | - | 2023-12-31 |
Mazen Darwazah
PRN | Corporate Officer/Principal | 67 | 2026-02-25 |
| Director | Title | Age | Since |
|---|---|---|---|
| Director/Board Member | 69 | 2005-10-13 | |
Khalid Nabilsi
BRD | Director/Board Member | 54 | 2025-12-14 |
Said Darwazah
CHM | Chairman | 68 | 2014-05-14 |
| Name | Varia. Jan 1. | Weight | AuM | |
|---|---|---|---|---|
 | +2.08% | 0.16% | 27 M€ |
| Change | 5d. change | 1-year change | 3-years change | Capi.($) | ||
|---|---|---|---|---|---|---|
| -0.11% | +4.20% | -26.92% | -24.35% | 4.04B | |
| -0.77% | -2.08% | +9.52% | +148.31% | 830B | |
| -1.49% | -3.26% | +46.50% | +41.94% | 564B | |
| -2.24% | -2.03% | +17.76% | +26.36% | 369B | |
| +2.07% | +1.39% | +25.20% | +16.28% | 328B | |
| -1.10% | -1.83% | +47.69% | +24.68% | 318B | |
| -1.65% | -3.56% | +50.13% | +2.60% | 294B | |
| -0.50% | -2.91% | +30.44% | +33.98% | 291B | |
| -1.45% | -0.25% | +26.28% | +42.22% | 192B | |
| -0.96% | +7.17% | -38.78% | -54.04% | 182B | |
| Average | -0.43% | +0.66% | +18.78% | +25.80% | 337.16B | |
| Weighted average by Cap. | -0.49% | -0.44% | +25.37% | +52.90% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 3.47B 2.94B 2.7B 2.56B 4.73B 322B 4.83B 31.63B 12.44B 156B 13B 12.73B 550B | 3.64B 3.09B 2.83B 2.69B 4.96B 338B 5.07B 33.18B 13.05B 163B 13.64B 13.35B 577B |
| Net income | 414M 351M 322M 306M 565M 38.48B 577M 3.78B 1.48B 18.56B 1.55B 1.52B 65.6B | 454M 385M 353M 335M 620M 42.22B 633M 4.14B 1.63B 20.37B 1.7B 1.67B 71.99B |
| Net Debt | 1.38B 1.17B 1.07B 1.02B 1.88B 128B 1.92B 12.55B 4.94B 61.71B 5.16B 5.05B 218B | 1.22B 1.03B 947M 900M 1.66B 113B 1.7B 11.11B 4.37B 54.65B 4.57B 4.47B 193B |
| Date | Price | Change | Volume |
|---|---|---|---|
| 26-04-20 | 1,377.50 p | -0.11% | 724,112 |
| 26-04-17 | 1,379.00 p | +2.68% | 585,744 |
| 26-04-16 | 1,343.00 p | -0.37% | 566,078 |
| 26-04-15 | 1,348.00 p | +0.60% | 717,825 |
| 26-04-14 | 1,340.00 p | +1.40% | 894,143 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Equities
- HIK Stock
Select your edition
All financial news and data tailored to specific country editions
